These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


757 related items for PubMed ID: 9313891

  • 21. Changes of D1 and D2 receptors in adult rat neostriatum after neonatal dopamine denervation: quantitative data from ligand binding, in situ hybridization and iontophoresis.
    Radja F, el Mansari M, Soghomonian JJ, Dewar KM, Ferron A, Reader TA, Descarries L.
    Neuroscience; 1993 Dec; 57(3):635-48. PubMed ID: 7906013
    [Abstract] [Full Text] [Related]

  • 22. The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys.
    Rioux L, Frohna PA, Joyce JN, Schneider JS.
    Mov Disord; 1997 Mar; 12(2):148-58. PubMed ID: 9087972
    [Abstract] [Full Text] [Related]

  • 23. The effects of electroconvulsive shock on dopamine-1 and dopamine-2 receptor ligand binding activity in MPTP-treated mice.
    Sershen H, Wolinsky T, Douyon R, Hashim A, Wiener HL, Lajtha A, Coons EE, Serby M.
    J Neuropsychiatry Clin Neurosci; 1991 Mar; 3(1):58-63. PubMed ID: 7580173
    [Abstract] [Full Text] [Related]

  • 24. Effects of GM1 ganglioside treatment on pre- and postsynaptic dopaminergic markers in the striatum of parkinsonian monkeys.
    Pope-Coleman A, Tinker JP, Schneider JS.
    Synapse; 2000 May; 36(2):120-8. PubMed ID: 10767059
    [Abstract] [Full Text] [Related]

  • 25. The expression of proenkephalin and prodynorphin genes and the induction of c-fos gene by dopaminergic drugs are not altered in the straitum of MPTP-treated mice.
    Ziolkowska B, Horn G, Kupsch A, Höllt V.
    J Neural Transm Park Dis Dement Sect; 1995 May; 9(2-3):151-64. PubMed ID: 8527000
    [Abstract] [Full Text] [Related]

  • 26. Ginkgo biloba extract (EGb 761) modulates the expression of dopamine-related genes in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice.
    Rojas P, Ruiz-Sánchez E, Rojas C, Ogren SO.
    Neuroscience; 2012 Oct 25; 223():246-57. PubMed ID: 22885234
    [Abstract] [Full Text] [Related]

  • 27. Levodopa or D2 agonist induced dyskinesia in MPTP monkeys: correlation with changes in dopamine and GABAA receptors in the striatopallidal complex.
    Calon F, Goulet M, Blanchet PJ, Martel JC, Piercey MF, Bédard PJ, Di Paolo T.
    Brain Res; 1995 May 22; 680(1-2):43-52. PubMed ID: 7663983
    [Abstract] [Full Text] [Related]

  • 28. Dopaminergic treatment weakens medium spiny neuron collateral inhibition in the parkinsonian striatum.
    Wei W, Ding S, Zhou FM.
    J Neurophysiol; 2017 Mar 01; 117(3):987-999. PubMed ID: 27927785
    [Abstract] [Full Text] [Related]

  • 29. Dopamine D1 receptor mRNA and receptor levels in the striatum of MPTP monkeys chronically treated with SKF-82958.
    Grondin R, Goulet M, Morissette M, Bédard PJ, Di Paolo T.
    Eur J Pharmacol; 1999 Aug 13; 378(3):259-63. PubMed ID: 10493101
    [Abstract] [Full Text] [Related]

  • 30. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
    Sirinathsinghji DJ, Heavens RP, McBride CS.
    Brain Res; 1988 Mar 08; 443(1-2):101-16. PubMed ID: 3258784
    [Abstract] [Full Text] [Related]

  • 31. Plasmalogen Augmentation Reverses Striatal Dopamine Loss in MPTP Mice.
    Miville-Godbout E, Bourque M, Morissette M, Al-Sweidi S, Smith T, Mochizuki A, Senanayake V, Jayasinghe D, Wang L, Goodenowe D, Di Paolo T.
    PLoS One; 2016 Mar 08; 11(3):e0151020. PubMed ID: 26959819
    [Abstract] [Full Text] [Related]

  • 32. Effect of the 5α-reductase enzyme inhibitor dutasteride in the brain of intact and parkinsonian mice.
    Litim N, Morissette M, Caruso D, Melcangi RC, Di Paolo T.
    J Steroid Biochem Mol Biol; 2017 Nov 08; 174():242-256. PubMed ID: 28982631
    [Abstract] [Full Text] [Related]

  • 33. Upregulation of striatal D2 receptors in the MPTP-treated vervet monkey is reversed by grafts of fetal ventral mesencephalon: an autoradiographic study.
    Elsworth JD, Brittan MS, Taylor JR, Sladek JR, Redmond DE, Innis RB, Zea-Ponce Y, Roth RH.
    Brain Res; 1998 Jun 08; 795(1-2):55-62. PubMed ID: 9622593
    [Abstract] [Full Text] [Related]

  • 34. Estrogen receptors and gonadal steroids in vulnerability and protection of dopamine neurons in a mouse model of Parkinson's disease.
    Al-Sweidi S, Morissette M, Bourque M, Di Paolo T.
    Neuropharmacology; 2011 Sep 08; 61(4):583-91. PubMed ID: 21586296
    [Abstract] [Full Text] [Related]

  • 35. Effect of chronic angiotensin-converting enzyme inhibition on striatal dopamine content in the MPTP-treated mouse.
    Jenkins TA, Wong JY, Howells DW, Mendelsohn FA, Chai SY.
    J Neurochem; 1999 Jul 08; 73(1):214-9. PubMed ID: 10386973
    [Abstract] [Full Text] [Related]

  • 36. High frequency electro-acupuncture enhances striatum DAT and D1 receptor expression, but decreases D2 receptor level in 6-OHDA lesioned rats.
    Rui G, Guangjian Z, Yong W, Jie F, Yanchao C, Xi J, Fen L.
    Behav Brain Res; 2013 Jan 15; 237():263-9. PubMed ID: 23036843
    [Abstract] [Full Text] [Related]

  • 37. Continuous subcutaneous infusion of apomorphine rescues nigro-striatal dopaminergic terminals following MPTP injection in mice.
    Battaglia G, Busceti CL, Cuomo L, Giorgi FS, Orzi F, De Blasi A, Nicoletti F, Ruggieri S, Fornai F.
    Neuropharmacology; 2002 Mar 15; 42(3):367-73. PubMed ID: 11897115
    [Abstract] [Full Text] [Related]

  • 38. Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity.
    Przedborski S, Kostic V, Jackson-Lewis V, Naini AB, Simonetti S, Fahn S, Carlson E, Epstein CJ, Cadet JL.
    J Neurosci; 1992 May 15; 12(5):1658-67. PubMed ID: 1578260
    [Abstract] [Full Text] [Related]

  • 39. D1 dopamine receptor-mediated induction of zif268 and c-fos in the dopamine-depleted striatum: differential regulation and independence from NMDA receptors.
    Keefe KA, Gerfen CR.
    J Comp Neurol; 1996 Apr 01; 367(2):165-76. PubMed ID: 8708002
    [Abstract] [Full Text] [Related]

  • 40. Prolonged alterations in canine striatal dopamine metabolism following subtoxic doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 4'-amino-MPTP are linked to the persistence of pyridinium metabolites.
    Johannessen JN, Sobotka TJ, Weise VK, Markey SP.
    J Neurochem; 1991 Sep 01; 57(3):981-90. PubMed ID: 1677682
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 38.